/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Angiotech Pharmaceuticals Inc.\n \n\n\n\n\n
Nov 23 7:02 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 09, 2009 7:08 AM EST
\n\n \n Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009 - CNW\n \n \n
\n\n Nov 09, 2009 7:04 AM EST
\n\n \n Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009 - PR Newswire\n \n \n
\n\n Oct 23, 2009 9:03 AM EDT
\n\n \n Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting - CNW\n \n \n
\n\n Oct 23, 2009 9:00 AM EDT
\n\n \n Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting - PR Newswire\n \n \n
\n\n Oct 19, 2009 4:31 PM EDT
\n\n \n Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission - CNW\n \n \n
\n\n Oct 19, 2009 4:30 PM EDT
\n\n \n Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission - PR Newswire\n \n \n
\n\n Oct 12, 2009 7:02 AM EDT
\n\n \n AnalystChoice.com Brings You the Best Complimentary Research Report on ASTM, CEGE, LINTA, AMSC, OCNF and ANPI - Marketwire\n \n \n
\n
\n\n");